A decennary update on diverse heterocycles and their intermediates as privileged scaffolds for cathepsin B inhibition
- 7 October 2022
- journal article
- review article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 222 (Pt B) , 2270-2308
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and SafetyChemical Research in Toxicology, 2011
- Proteases for Processing Proneuropeptides into Peptide Neurotransmitters and HormonesAnnual Review of Pharmacology and Toxicology, 2008
- Total synthesis of miraziridine A and identification of its major reaction site for cathepsin BTetrahedron, 2007
- Two biflavonoids from Ouratea nigroviolaceaPhytochemistry, 2006
- Human pancreatitis and the role of cathepsin BGut, 2006
- The role of cathepsins in osteoporosis and arthritis: Rationale for the design of new therapeuticsAdvanced Drug Delivery Reviews, 2005
- Cathepsin B carboxydipeptidase specificity analysis using internally quenched fluorescent peptidesBiochemical Journal, 2002
- Role of the Occluding Loop in Cathepsin B ActivityJournal of Biological Chemistry, 1997
- Aziridine Analogs of [[trans-(Epoxysuccinyl)-L-leucyl]amino]-4-guanidinobutane (E-64) as Inhibitors of Cysteine ProteasesJournal of Medicinal Chemistry, 1995
- LEUPEPTINS, NEW PROTEASE INHIBITORS FROM ACTINOMYCETESThe Journal of Antibiotics, 1969